secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001628280-24-045012
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 1.02, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q3 2024 revenue down 40.6% to $140.2M; EPS $0.10; guides Q4 revenue $100-120M
--------------------------------------------------------------------------------

- Revenue $140.2M, down 40.6% YoY; net income $1.1M ($0.10 diluted EPS); adjusted EPS $0.35.
- Active earning OPTAVIA coaches fell 36.3% to 30,000; average revenue per coach $4,672 (down from $5,008).
- Cash $170M, no debt; credit facility canceled, saving ~$500k annual commitment fees.
- Q4 2024 guidance: revenue $100-120M, diluted loss per share $0.10-$0.65.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828024045012/0001628280-24-045012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828024045012/med-20241030.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-045012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer